Licking Memorial Health Systems - Measurably different...for your health
Community > Press Releases > LMH Recognized for Outstanding Performance in Treating Heart Attack Patients
LMH Recognized for Outstanding Performance in Treating Heart Attack Patients

LMH Recognized for Outstanding Performance in Treating Heart Attack Patients Licking Memorial Hospital (LMH) recently was recognized by the American Heart Association with the Mission: Lifeline® Receiving Center Gold Level Recognition Award for its outstanding performance and high quality care for treating heart attack patients.  The Mission: Lifeline® program recognizes the importance of swift treatment following a heart attack, and aims to improve the quality and efficiency of care for patients diagnosed with an ST-elevation myocardial infarction (STEMI) and a Non-ST-elevation myocardial infarction (NSTEMI).

A myocardial infarction is the medical term for a heart attack.  ST refers to the ST segment, which is part of the EKG heart tracing used to diagnose a heart attack.  A STEMI is a form of heart attack which involves a sudden blockage of one of the arteries that supply blood to the heart.  An NSTEMI is caused by partial or temporary coronary artery blockages.

To earn the Gold Level Recognition Award for STEMI care, hospitals that receive and treat STEMI patients must meet or exceed guidelines set by the American Heart Association that include performing lifesaving procedures, such as a stent, within 90 minutes of arrival.  For NSTEMI care, hospitals are recognized for adherence to guidelines for prompt treatment beginning with the 911 call continuing through discharge.  “LMH is dedicated to providing excellent care for patients who suffer a heart attack.  The nationally respected clinical guidelines recognize the importance of prompt attention in preserving heart muscle and saving lives,” said Licking Memorial Health Systems President & CEO Rob Montagnese.  The Cardiology Department specializes in providing timely lifesaving techniques as well as the latest technology for patients at risk of cardiovascular disease.